Evidence map›Paper›PMID 29992435›Full record

ArticleApplied microbiology and biotechnology2018

Identification and characterisation of short chain rhamnolipid production in a previously uninvestigated, non-pathogenic marine pseudomonad.

Matthew S Twigg, L Tripathi, A Zompra, K Salek, V U Irorere, T Gutierrez, G A Spyroulias, R Marchant, I M Banat

Open access · hybridAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Manganese-oxidizingFrontiers in microbiology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Biogenic propane production by a marineFrontiers in microbiology · 2022
    Article
  14. Achieving Commercial Applications for Microbial Biosurfactants.Advances in biochemical engineering/biotechnology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Matthew S TwiggSchool of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK. m.twigg@ulster.ac.uk.ORCID http://orcid.org/0000-0002-8601-1960
L TripathiSchool of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.
A ZompraDepartment of Pharmacy, University of Patras, 26504, Patras, Greece.
K SalekInstitute of Mechanical, Process and Energy Engineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, EH14 4AS, UK.
V U IrorereSchool of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.
T GutierrezInstitute of Mechanical, Process and Energy Engineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, EH14 4AS, UK.
G A SpyrouliasDepartment of Pharmacy, University of Patras, 26504, Patras, Greece.
R MarchantSchool of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.
I M BanatSchool of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.
University of Ulster · GBHeriot-Watt University · GBUniversity of Patras · GR

Funding

Horizon 2020 635340
6 · The paper itself

Abstract

This study aimed to identify and characterise biosurfactant compounds produced by bacteria associated with a marine eukaryotic phytoplankton bloom. One strain, designated MCTG214(3b1), was isolated by enrichment with polycyclic aromatic hydrocarbons and based on 16S rDNA, and gyrB sequencing was found to belong to the genus Pseudomonas, however not related to P. aeruginosa. Cell-free supernatant samples of strain MCTG214(3b1) at stationary phase showed significant reductions in surface tension. HPLC-MS and NMR analysis of these samples indicated the presence of five different rhamnolipid (RL) congeners. Di-rhamnolipids accounted for 87% relative abundance and all congeners possessed fatty acid moieties consisting of 8-12 carbons. PCR screening of strain MCTG214(3b1) DNA revealed homologues to the P. aeruginosa RL synthesis genes rhlA and rhlB; however, no rhlC homologue was identified. Using the Galleria mellonella larvae model, strain MCTG214(3b1) was demonstrated to be far less pathogenic than P. aeruginosa. This study identifies for the first time a significantly high level of synthesis of short chain di-rhamnolipids by a non-pathogenic marine Pseudomonas species. We postulate that RL synthesis in Pseudomonas sp. MCTG214(3b1) is carried out by enzymes expressed from rhlA/B homologues similar to those of P. aeruginosa; however, a lack of rhlC potentially indicates the presence of a second novel rhamnosyltransferase responsible for the di-rhamnolipid congeners identified by HPLC-MS.

Indexed as

AnimalsBacterial ProteinsDNA GyraseGlycolipidsPseudomonasPseudomonas aeruginosaRNA, Ribosomal, 16SSeawaterSequence Analysis, DNASurface-Active AgentsBacterial ProteinsDNA GyraseGlycolipidsrhamnolipidRNA, Ribosomal, 16SSurface-Active AgentsBiosurfactantMarine bacteriaNon-pathogenicPseudomonasRhamnolipid

Identifiers

PMID29992435
PMCPMC6153872
OpenAlexW2826928445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.